Plasma adenosine 3',5'-cyclic monophosphate in human hypertension.
In a previous study we observed an increase in urinary cyclic AMP in labile hypertension in the upright position and during isoproterenol infusion, in contrast to a decrease in control subjects. In the present study we measured the plasma level of cyclic AMP in control subjects and patients with various types of hypertension. We obtained the following results: (1) plasma cyclic AMP increases in response to upright posture in control subjects and hypertensive patients; (2) values of cyclic AMP in the recumbent and upright positions are comparable in control subjects and patients with essential hypertension, but are significantly higher in those with true renovascular hypertension due to bilateral renal artery stenosis; (3) propranolol inhibits the increase of plasma cyclic AMP in response to posture in control subjects, but has an opposite effect in labile hypertension where there is a further increase; (4) the rise in blood pressure in pheochromocytoma is associated with a considerable increase in plasma cyclic AMP.Present and previous data suggest that kidney handling of cyclic AMP is abnormal in hypertension, and that the specific defect may be related to the type of hypertension.
D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000097:blood / Q000652:urine; D000328:Adult; D001161:Arteriosclerosis / Q000097:blood / Q000652:urine; D001794:Blood Pressure; D002648:Child; D002986:Clinical Trials as Topic; D000242:Cyclic AMP / Q000097:blood* / Q000652:urine; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000652:urine; D006977:Hypertension, Renal / Q000097:blood / Q000652:urine; D008297:Male; D008875:Middle Aged; D010673:Pheochromocytoma / Q000097:blood / Q000652:urine; D010919:Placebos; D011187:Posture; D011433:Propranolol / Q000494:pharmacology; D012078:Renal Artery Obstruction / Q000097:blood / Q000652:urine
D010919:Placebos; D011433:Propranolol; D000242:Cyclic AMP